Related Experiment Video
Updated: Jun 19, 2026
09:00
Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
Behaviour of ceftazidime towards beta-lactamases
R Labia1, R Beguin-Billecoq, M Guionie
1CNRS-CERCOA, B.P. 28, 94320 Thiais, France.
The Journal of Antimicrobial Chemotherapy
|October 8, 2009
Summary
Ceftazidime showed limited interaction with common beta-lactamases, requiring higher concentrations than cefotaxime or cefuroxime. However, ceftazidime demonstrated greater stability against these enzymes in microbiological tests.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Beta-lactamase enzymes confer bacterial resistance to beta-lactam antibiotics.
- Understanding antibiotic-beta-lactamase interactions is crucial for developing effective treatments.
- Ceftazidime, cefotaxime, and cefuroxime are important beta-lactam antibiotics.
Purpose of the Study:
- To evaluate the interaction of ceftazidime with various beta-lactamases.
- To compare the stability of ceftazidime, cefotaxime, and cefuroxime against beta-lactamases.
Main Methods:
- Determination of inhibition constants (Ki) for ceftazidime, cefotaxime, and cefuroxime against purified beta-lactamases.
- Utilizing the double-disc microbiological technique to assess antibiotic stability.
Main Results:
- Ceftazidime exhibited significantly higher inhibition constants (Ki) compared to cefotaxime and cefuroxime against enzymes from Escherichia coli, Enterobacter cloacae, Proteus morganii, and Pseudomonas aeruginosa.
- Minimal interaction was observed between ceftazidime and beta-lactamases from Pr. vulgaris and Klebsiella oxytoca.
- The double-disc method revealed ceftazidime to be more stable than cefotaxime against all tested beta-lactamases.
- Moxalactam displayed slightly superior stability compared to ceftazidime.
Conclusions:
- Ceftazidime is less effective against a range of common beta-lactamases compared to cefotaxime and cefuroxime, indicated by higher Ki values.
- Despite lower inhibitory potency, ceftazidime demonstrates enhanced stability against beta-lactamase degradation.
- These findings highlight the complex relationship between antibiotic structure, enzyme interaction, and stability in overcoming bacterial resistance.
More Related Videos
07:47Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
05:06Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.